PEAK-1 Study – Clear cell Renal Cell Carcinoma

  Inclusion (Minimum requirements)  Aged 18 years and above  Unresectable (cannot be surgically removed or fully removed/resected), locally advanced or metastatic renal cell carcinoma with a primary clear cell component.  You have had previous immunotherapy treatment (anti-PD-1 or anti-PD-L) but your cancer has progressed or has not responded to the treatment   Exclusion (Generally not allowed)  Received prior treatment with a HIF-2α inhibitor or cabozantinib.  Have had another active cancer within the […]